Publications by authors named "M Bunte"
Unlabelled: The Sars coronavirus 2019 (COVID-19) pandemic has resulted in increased morbidity and mortality; however, there is limited understanding of how excess mortality is distributed among different racial and ethnic subgroups and vascular diseases.
Methods: We conducted a retrospective, cross-sectional study design using data from the United States (US) Center for Disease Control (CDC) Wide Ranging Online Data for Epidemiologic Research (Wonder) database. The database contains death certificate information for all US residents by cause of death as ascertained by the treating physician.
This analysis aimed to estimate 30-day episode care costs associated with 3 contemporary endovascular therapies indicated for treatment of pulmonary embolism (PE). Systematic literature review was used to identify clinical research reporting costs associated with invasive PE care and outcomes for ultrasound-accelerated thrombolysis (USAT), continuous-aspiration mechanical thrombectomy (CAMT), and volume-controlled-aspiration mechanical thrombectomy (VAMT). Total episode variable care costs were defined as the sum of device costs, variable acute care costs, and contingent costs.
View Article and Find Full Text PDFComparison of anticoagulation vs mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis.
J Vasc Surg Venous Lymphat Disord
July 2024
Objective: To compare the comparative effects of treatment with contemporary mechanical thrombectomy (MT) or anticoagulation (AC) on Villalta scores and post-thrombotic syndrome (PTS) incidence through 12 months in iliofemoral deep vein thrombosis (DVT).
Methods: Patients with DVT in the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) randomized trial and the ClotTriever Outcomes (CLOUT) registry were included in this analysis. Both studies evaluated the effects of thrombus removal on the incidence of PTS.
Article Synopsis
- Systemic thrombolysis (ST) is the standard treatment for high-risk pulmonary embolism (PE), but catheter-directed thrombolysis (CDT) may pose a lower bleeding risk; trends and outcomes for high-risk PE treatments remain poorly documented.
- A study analyzing data from 74,516 hospitalized patients with high-risk PE between 2016-2019 found that the majority received no lytic therapy (NLT), while ST and CDT were used less frequently; those receiving NLT were typically older and had more female patients.
- The findings revealed higher in-hospital mortality rates for ST compared to CDT and NLT, with CDT showing significantly lower rates of intracranial hemorrhage (ICH) and gastrointestinal bleeding (GIB